The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Carestream equipment is highly recommended for its imaging quality
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Acute therapies continue to report strong growth compared to chronic ones.
The MoU was signed on World Organ Donation Day which falls on August 13
Subscribe To Our Newsletter & Stay Updated
